心脏冲击结果中的种族差异:单中心回顾性研究
Rafik I Issa1, Sarah K Adie2, Vince D Marshall3
1Rafik I. Issa is an internal medicine physician, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.
概括
与白人患者相比,患有心脏性休克的黑人患者住院时间较长,但死亡率相似. 这项研究突出了对心脏性休克的黑人护理的潜在差异.
科学领域:
- 心脏病学
- 医疗服务研究
- 医疗公平
背景情况:
- 种族对心血管疾病的结果有很大影响,但对心血管休克的影响尚不清楚.
- 了解心脏性休克的种族差异对于公平的患者护理至关重要.
研究的目的:
- 研究种族对心脏性休克患者的结果的影响.
- 确定不同种族群体对心脏性休克的治疗和结果的潜在差异.
主要方法:
- 一项回顾性队列研究分析了2019年6月至2023年6月期间因心脏性休克住院的2458名成年患者.
- 患者被分为白人,黑人和其他种族组进行比较分析.
- 使用倾向性评分来比较死亡率,停留时间和机械支的使用.
主要成果:
- 黑人患者年轻,有较高的器官衰竭评估分数,更有可能从住院病房入院.
- 种族之间没有观察到医院或心脏重症监护室死亡率的显著差异.
- 与白人患者相比,黑人患者在医院和心脏重症监护室的停留时间明显长.
结论:
- 虽然死亡率相似,但黑人患者的住院时间较长表明临床治疗可能存在差异.
- 需要进一步的研究来解决和纠正心脏性休克治疗的不公平.
- 这些发现强调了在心血管结果研究中考察种族的重要性.
更多相关视频
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52


